VistaGen Therapeutics, Inc. (VTGN): Price and Financial Metrics
VTGN Price/Volume Stats
| Current price | $2.61 | 52-week high | $5.86 |
| Prev. close | $2.67 | 52-week low | $2.52 |
| Day low | $2.52 | Volume | 234,200 |
| Day high | $2.67 | Avg. volume | 194,628 |
| 50-day MA | $3.01 | Dividend yield | N/A |
| 200-day MA | $3.85 | Market Cap | 72.67M |
VTGN Stock Price Chart Interactive Chart >
VistaGen Therapeutics, Inc. (VTGN) Company Bio
VistaGen Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops products for patients with diseases and disorders involving the central nervous system. VistaGen Therapeutics serves customers in the United States.
VTGN Price Returns
| 1-mo | -15.81% |
| 3-mo | -28.88% |
| 6-mo | -36.03% |
| 1-year | -22.09% |
| 3-year | -95.58% |
| 5-year | -74.31% |
| YTD | -49.22% |
| 2023 | 66.34% |
| 2022 | -94.72% |
| 2021 | 0.52% |
| 2020 | 181.28% |
| 2019 | -54.02% |
Loading social stream, please wait...